Diagnostics and therapy of gout – editorial
Authors:
Petr Bradna
Authors place of work:
II. interní gastroenterologická klinika LF UK a FN Hradec Králové, přednostka prof. MUDr. Marcela Kopáčová, Ph. D.
Published in the journal:
Vnitř Lék 2015; 61(6): 507-508
Category:
Editorials
Zdroje
1.Kingsbury SR, Conaghan PG, McDermott MF. The role of the NLRP3 inflammasome in gout. J Inflamm Res 2011; 4: 39–49.
2.Singh JA. When gout goes to the heart: does gout equal a cardiovascular disease risk factor? Ann Rheum Dis 2015; 74(4):631–634. Dostupné z DOI: <http://dx.doi.org/ 10.1136/annrheumdis-2014–206432>.
3.Pascual E, Andrés M, Vela P. Gout treatment: should we aim for rapid crystal dissolution? Ann Rheum Dis 2013; 72(5): 635–637.
Štítky
Diabetology Endocrinology Internal medicineČlánok vyšiel v časopise
Internal Medicine
2015 Číslo 6
Najčítanejšie v tomto čísle
- Diagnosing and therapy of gout
- Guidelines of Czech Association for Thrombosis and Haemostasis of the Czech Medical Association of J. E. Purkyně for safety treatment with new oral anticoagulants (NOAC) – dabigatran etexilate, apixaban and rivaroxaban
- “Stressful holiday” – takotsubo cardiomyopathy
- Alveolar echinococcosis – rare cystic disease of the liver – editorial